Advancements in Pharmaceutical Quality Control and Clinical Research Coordination: Bridging Gaps in Global Healthcare Standards

References

[1] ABOUHUSSEIN, D., SABRY, P., & MOGHAWRY, H. M. (2019). Recent insight into critical concerns in international quality regulations governing the pharmaceutical industry: A Review. International Journal of Pharmaceutical Research (09752366), 11(1).

[2] Alemede, V., Usuemerai, P. A., & Ibikunle, O. E. (2023). Digital entrepreneurship in US pharmaceuticals: Integrating marketing innovation and supply chain efficiency.

[3] Apostolaros, M., Babaian, D., Corneli, A., Forrest, A., Hamre, G., Hewett, J., . . . Randall, P. (2020). Legal, regulatory, and practical issues to consider when adopting decentralized clinical trials: recommendations from the clinical trials transformation initiative. Therapeutic Innovation & Regulatory Science, 54, 779-787.

[4] Ayalew, K., Ning, Y.-M., Foringer, M. J., Leibenhaut, S., Sellers, J. W., Yu, B., . . . Rodriguez, M. (2023). Comparison of good clinical practice inspection processes for marketing applications between the United States Food and Drug Administration and the European Medicines Agency. Therapeutic Innovation & Regulatory Science, 57(1), 79-85.

[5] Bhati, C., Minocha, N., Purohit, D., Kumar, S., Makhija, M., & Saini, S. (2022). High performance liquid chromatography: recent patents and advancement. Biomedical and Pharmacology Journal, 15(2), 729-746.

[6] Brown, D. G., & Wobst, H. J. (2021). A decade of FDA-approved drugs (2010–2019): trends and future directions. Journal of medicinal chemistry, 64(5), 2312-2338.

[7] Bustin, S. A., & Jellinger, K. A. (2023). Advances in molecular medicine: unravelling disease complexity and pioneering precision healthcare. In (Vol. 24, pp. 14168): MDPI.

[8] Chakravarty, S. (2022). Resource constrained innovation in a technology intensive sector: Frugal medical devices from manufacturing firms in South Africa. Technovation, 112, 102397.

[9] Cherrington, A. L., Krause-Steinrauf, H., Aroda, V., Buse, J. B., Fattaleh, B., Fortmann, S. P., . . . Killean, T. (2023). Use of comprehensive recruitment strategies in the Glycemia reduction approaches in diabetes: a comparative effectiveness study (GRADE) multi-center clinical trial. Clinical Trials, 20(5), 546-558.

[10] Chowdhury, M. (2021). A broken system? Examining the perilous state of quality assurance in crime scene practice. Science & Justice, 61(5), 564-572.

[11] Christiansen, G. D. (2020). Quality control and quality assurance issues in biopharmaceutical processing. In Biotechnology (pp. 33-71): CRC Press.

[12] Church, D. L., & Naugler, C. (2019). Benefits and risks of standardization, harmonization and conformity to opinion in clinical laboratories. Critical Reviews in Clinical Laboratory Sciences, 56(5), 287-306.

[13] Clegg, I. (2020). Process analytical technology. In Specification of Drug Substances and Products (pp. 149-173): Elsevier.

[14] Dang, A. (2023). Real-world evidence: a primer. Pharmaceutical medicine, 37(1), 25-36.

[15] Denham, B. (2020). Magazine journalism in the golden age of muckraking: Patent-medicine exposures before and after the Pure Food and Drug Act of 1906. Journalism & Communication Monographs, 22(2), 100-159.

[16] Ganu, G. (2020). Advance Concepts of Clinical Research Guidance for Industry: Sankalp Publication.

[17] Green, M. R., & Sambrook, J. (2019). Polymerase chain reaction. Cold Spring Harbor Protocols, 2019(6), pdb. top095109.

[18] Hashem, H., Abufaraj, M., Tbakhi, A., & Sultan, I. (2020). Obstacles and considerations related to clinical trial research during the COVID-19 pandemic. Frontiers in medicine, 7, 598038.

[19] Hassan, M. A.-K., & Aliyu, S. (2022). Delayed access to COVID-19 vaccines: a perspective on low-income countries in Africa. International Journal of Health Services, 52(3), 323-329.

[20] Javed, S., & Chattu, V. K. (2020). Strengthening the COVID-19 pandemic response, global leadership, and international cooperation through global health diplomacy. Health promotion perspectives, 10(4), 300.

[21] Li, D., & Gaquerel, E. (2021). Next-generation mass spectrometry metabolomics revives the functional analysis of plant metabolic diversity. Annual Review of Plant Biology, 72(1), 867-891.

[22] Lindström‐Gommers, L., & Mullin, T. (2019). International conference on harmonization: recent reforms as a driver of global regulatory harmonization and innovation in medical products. Clinical Pharmacology & Therapeutics, 105(4), 926-931.

[23] Madariaga, A., Kasherman, L., Karakasis, K., Degendorfer, P., Heesters, A. M., Xu, W., . . . Oza, A. M. (2021). Optimizing clinical research procedures in public health emergencies. Medicinal Research Reviews, 41(2), 725-738.

[24] McClure, J., Asghar, A., Krajec, A., Johnson, M. R., Subramanian, S., Caroff, K., . . . Beck, D. J. (2023). Clinical trial facilitators: a novel approach to support the execution of clinical research at the study site level. Contemporary Clinical Trials Communications, 33, 101106.

[25] Mukherjee, P. K. (2019). Quality control and evaluation of herbal drugs: Evaluating natural products and traditional medicine: Elsevier.

[26] Ninduwezuor-Ehiobu, N., Tula, O. A., Daraojimba, C., Ofonagoro, K. A., Ogunjobi, O. A., Gidiagba, J. O., . . . Banso, A. A. (2023). Exploring innovative material integration in modern manufacturing for advancing us competitiveness in sustainable global economy. Engineering Science & Technology Journal, 4(3), 140-168.

[27] Nordo, A. H., Levaux, H. P., Becnel, L. B., Galvez, J., Rao, P., Stem, K., . . . Kush, R. D. (2019). Use of EHRs data for clinical research: historical progress and current applications. Learning health systems, 3(1), e10076.

[28] Ojha, A., & Bhargava, S. (2022). International council for harmonisation (ICH) guidelines. In Regulatory affairs in the pharmaceutical industry (pp. 47-74): Elsevier.

[29] Organization, W. H. (2019). WHO benchmarks for International Health Regulations (IHR) capacities: World Health Organization.

[30] Organization, W. H. (2021). WHO Global Benchmarking Tool (GBT) for evaluation of national regulatory systems of medical products: revision VI: World Health Organization.

[31] Organization, W. H. (2022). Global report on health equity for persons with disabilities: World Health Organization.

[32] Park, Y. L., & Canaway, R. (2019). Integrating traditional and complementary medicine with national healthcare systems for universal health coverage in Asia and the Western Pacific. Health Systems & Reform, 5(1), 24-31.

[33] Phelan, H., Yates, V., & Lillie, E. (2022). Challenges in healthcare delivery in low-and middle-income countries. Anaesthesia & Intensive Care Medicine, 23(8), 501-504.

[34] Raut, N., Bajaj, K., Matte, P., Vhora, M., Kale, V., Umekar, M., & Harane, S. (2023). Building Bridges: Harmonization efforts for enhanced collaboration between developed and developing countries. International Journal Of Drug Regulatory Affairs, 11(3), 68-79.

[35] Rubinger, L., Gazendam, A., Ekhtiari, S., & Bhandari, M. (2023). Machine learning and artificial intelligence in research and healthcare. Injury, 54, S69-S73.

[36] Sardella, M., Belcher, G., Lungu, C., Ignoni, T., Camisa, M., Stenver, D. I., . . . Adams, A. (2021). Monitoring the manufacturing and quality of medicines: a fundamental task of pharmacovigilance. Therapeutic Advances in Drug Safety, 12, 20420986211038436.

[37] Tang, M., Joensuu, H., Simes, R. J., Price, T. J., Yip, S., Hague, W., . . . Zalcberg, J. (2019). Challenges of international oncology trial collaboration—a call to action. British Journal of Cancer, 121(7), 515-521.

[38] Tzenios, N. (2019). The determinants of Access to Healthcare: a review of Individual, Structural, and systemic factors. Journal of Humanities and Applied Science Research, 2(1), 1-14.

[39] Verna, E. C., Serper, M., Chu, J., Corey, K., Fix, O. K., Hoyt, K., . . . Everson, G. T. (2020). Clinical research in hepatology in the COVID‐19 pandemic and post‐pandemic era: challenges and the need for innovation. Hepatology, 72(5), 1819-1837.

[40] Voykelatos, G. (2022). Good Manufacturing Practices (GMPs) and process validation in the pharmaceutical industry: an in depth analysis. Πανεπιστήμιο Πειραιώς,

[41] Wang, H., Chen, Y., Wang, L., Liu, Q., Yang, S., & Wang, C. (2023). Advancing herbal medicine: enhancing product quality and safety through robust quality control practices. Frontiers in Pharmacology, 14, 1265178.

[42] Warner, J. J., Crook, H. L., Whelan, K. M., Bleser, W. K., Roiland, R. A., Hamilton Lopez, M., . . . McClellan, M. B. (2020). Improving cardiovascular drug and device development and evidence through patient-centered research and clinical trials: a call to action from the value in healthcare initiative’s partnering with regulators learning collaborative. Circulation: Cardiovascular Quality and Outcomes, 13(7), e006606.

[43] Wasalathanthri, D. P., Rehmann, M. S., Song, Y., Gu, Y., Mi, L., Shao, C., . . . Borys, M. C. (2020). Technology outlook for real‐time quality attribute and process parameter monitoring in biopharmaceutical development—A review. Biotechnology and Bioengineering, 117(10), 3182-3198.

[44] Weissler, E. H., Naumann, T., Andersson, T., Ranganath, R., Elemento, O., Luo, Y., . . . Khan, F. (2021). The role of machine learning in clinical research: transforming the future of evidence generation. Trials, 22, 1-15.

[45] Wilson, J. L., Wong, M., Chalke, A., Stepanov, N., Petkovic, D., & Altman, R. B. (2019). PathFXweb: a web application for identifying drug safety and efficacy phenotypes. Bioinformatics, 35(21), 4504-4506.

[46] Witter, S., Sheikh, K., & Schleiff, M. (2022). Learning health systems in low-income and middle-income countries: exploring evidence and expert insights. BMJ Global Health, 7(Suppl 7), e008115.

[47] Xu, X., Jiang, W., Chen, L., Xu, Z., Zhang, Q., Zhu, M., . . . Zhou, X. (2021). Evaluation of the safety and efficacy of using human menstrual blood‐derived mesenchymal stromal cells in treating severe and critically ill COVID‐19 patients: an exploratory clinical trial. Clinical and translational medicine, 11(2), e297.

[48] Zozus, M. N., Sanns, W., Eisenstein, E., & Sanns, B. (2021). Beyond EDC. Journal of the Society for Clinical Data Management, 1(1).

@article{1705018,
      author = {Cordia Peter Ogbeta, Akachukwu Obianuju Mbata, Kenneth Udemezue katas, Rinji Goshit Kassem},
      title = {Advancements in Pharmaceutical Quality Control and Clinical Research Coordination: Bridging Gaps in Global Healthcare Standards},
      journal = {Iconic Research And Engineering Journals},
      year = {2023},
      volume = {7},
      number = {3},
      pages = {678-688},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1705018.pdf},
      abstract = {This paper explores pharmaceutical quality control (QC) advancements and clinical research coordination, emphasizing their role in bridging gaps in global healthcare standards. It examines the historical evolution of pharmaceutical QC, highlighting key technological innovations such as High-Performance Liquid Chromatography and real-time process monitoring, which have significantly enhanced drug safety, efficacy, and quality assurance. The paper further discusses recent developments in clinical trial methodologies, including adaptive designs, patient-centric approaches, and the increasing role of technology in improving trial coordination and efficiency. Additionally, it addresses the importance of multi-center and global collaborations in clinical research, which contribute to more diverse and representative trials. The paper also identifies existing disparities in healthcare standards, particularly between high-income and low- and middle-income countries, and reviews ongoing international efforts to harmonize pharmaceutical regulations and clinical research practices. Finally, recommendations are provided for future advancements, including the continued harmonization of regulatory frameworks, investment in emerging technologies, capacity building in underserved regions, and greater emphasis on patient-centric approaches. These recommendations aim to foster global healthcare equity, improve access to safe and effective treatments, and ensure more inclusive and efficient clinical research practices worldwide.},
      keywords = {Pharmaceutical Quality Control, Clinical Research Coordination, Global Healthcare Standards, Adaptive Trial Design, Technological Innovation},
      month = {September},
  }